UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2025
or
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to
____________
Commission File Number: 001-42720
Yorkville Acquisition Corp.
(Exact name of registrant
as specified in its charter)
Cayman Islands | | N/A |
(State or other jurisdiction of
incorporation or organization) | | (I.R.S. Employer
Identification No.) |
1012 Springfield Avenue
Mountainside, New Jersey 07092
(Address of principal
executive offices, including zip code)
(201) 985-8300
(Registrant’s
telephone number, including area code)
N/A
(Former name, former
address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant | | YORKU | | The Nasdaq Stock Market LLC |
Class A ordinary shares, par value $0.0001 per share | | YORK | | The Nasdaq Stock Market LLC |
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | | YORKW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. ☒ Yes ☐ No
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒
Yes ☐ No
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☒ Yes ☐ No
As of August 14, 2025, the registrant had a total of 17,831,250
Class A ordinary shares, $0.0001 par value, issued and outstanding and 5,750,000 Class B ordinary shares, $0.0001 par value, issued and
outstanding.
YORKVILLE ACQUISITION CORP.
JUNE 30, 2025
TABLE OF
CONTENTS
|
Page |
PART
I - FINANCIAL INFORMATION |
1 |
Item
1. |
Interim
Financial Statements. |
1 |
|
Unaudited Condensed Balance Sheet as of June 30, 2025 |
1 |
|
Unaudited Condensed Statements of Operations for the three months ended June 30, 2025 and for the period from March 3, 2025 (inception)
through June 30, 2025 |
2 |
|
Unaudited Condensed Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit for the three
months ended June 30, 2025 and for the period from March 3, 2025 (inception) through June 30, 2025 |
3 |
|
Unaudited Condensed Statements of Cash Flows for the period from March 3, 2025 (inception) through June 30, 2025 |
4 |
|
Notes to Unaudited Condensed Financial Statements |
5 |
Item
2. |
Management’s
Discussion and Analysis of Financial Condition and Results of Operations |
19 |
Item
3. |
Quantitative
and Qualitative Disclosures About Market Risk |
22 |
Item
4. |
Controls
and Procedures |
22 |
PART
II - OTHER INFORMATION |
23 |
Item
1. |
Legal
Proceedings |
23 |
Item
1.A. |
Risk
Factors |
23 |
Item
2. |
Unregistered
Sales of Equity Securities and Use of Proceeds. |
23 |
Item
3. |
Defaults
Upon Senior Securities |
23 |
Item
4. |
Mine
Safety Disclosures |
23 |
Item
5. |
Other
Information |
23 |
Item
6. |
Exhibits |
24 |
PART
III - SIGNATURES |
25 |
PART I - FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
YORKVILLE ACQUISITION CORP.
UNAUDITED CONDENSED BALANCE SHEET
JUNE 30, 2025
Assets: | |
| |
Current assets | |
| |
Cash | |
$ | 1,467,830 | |
Prepaid expenses | |
| 85,000 | |
Total current assets | |
| 1,552,830 | |
Cash held in Trust Account | |
| 173,362,500 | |
Total Assets | |
$ | 174,915,330 | |
| |
| | |
Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders’ Deficit: | |
| | |
Current liabilities | |
| | |
Accrued offering costs | |
$ | 573,472 | |
Promissory note – related party | |
| 124,723 | |
Accrued expenses | |
| 8,801 | |
Accounts payable | |
| 30,680 | |
Total current liabilities | |
| 737,676 | |
Deferred underwriting commissions | |
| 5,175,000 | |
Total Liabilities | |
| 5,912,676 | |
| |
| | |
Commitments and Contingencies (Note 7) | |
| | |
Class A ordinary shares subject to possible redemption, $0.0001 par value; 17,250,000 shares issued and outstanding at redemption value of $10.05 per share | |
| 173,362,500 | |
| |
| | |
Shareholders’ Deficit | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
| — | |
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 581,250 shares issued and outstanding (excluding 17,250,000 shares subject to possible redemption) | |
| 58 | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding(1) | |
| 575 | |
Additional paid-in capital | |
| — | |
Accumulated deficit | |
| (4,360,479 | ) |
Total Shareholders’ Deficit | |
| (4,359,846 | ) |
Total Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders’ Deficit | |
$ | 174,915,330 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
YORKVILLE ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
| |
For the Three Months Ended June 30, 2025 | | |
For the Period from March 3, 2025 (inception) to June 30, 2025 | |
Formation, general and administrative expenses | |
$ | 63,574 | | |
$ | 93,998 | |
Loss from operations | |
| (63,574 | ) | |
| (93,998 | ) |
| |
| | | |
| | |
Other income: | |
| | | |
| | |
Interest income | |
| 1,864 | | |
| 1,864 | |
Other income, net | |
| 1,864 | | |
| 1,864 | |
Net loss | |
$ | (61,710 | ) | |
$ | (92,134 | ) |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption | |
| 189,560 | | |
| 143,750 | |
| |
| | | |
| | |
Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption | |
$ | (0.01 | ) | |
$ | (0.02 | ) |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, non-redeemable Class A ordinary shares | |
| 6,387 | | |
| 4,844 | |
| |
| | | |
| | |
Basic and diluted net loss per share, non-redeemable Class A ordinary shares | |
$ | (0.01 | ) | |
$ | (0.02 | ) |
| |
| | | |
| | |
Basic weighted average shares outstanding, non-redeemable Class B ordinary shares(1) | |
| 5,008,242 | | |
| 5,006,250 | |
| |
| | | |
| | |
Basic net loss per share, non-redeemable Class B ordinary shares | |
$ | (0.01 | ) | |
$ | (0.02 | ) |
| |
| | | |
| | |
Diluted weighted average shares
outstanding, non-redeemable Class B ordinary shares | |
| 5,750,000 | | |
| 5,750,000 | |
| |
| | | |
| | |
Diluted net loss per share, non-redeemable Class B ordinary shares | |
$ | (0.01 | ) | |
$ | (0.02 | ) |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
YORKVILLE
ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN
SHAREHOLDERS’ DEFICIT
| |
Class A | | |
Class B | | |
Additional | | |
| | |
Total | |
| |
Ordinary Shares | | |
Ordinary Shares | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance –
March 3, 2025 (inception) | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
Class
B ordinary shares issued to Sponsor | |
| — | | |
| — | | |
| 5,750,000 | | |
| 575 | | |
| 24,425 | | |
| — | | |
| 25,000 | |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (30,424 | ) | |
| (30,424 | ) |
Balance - March 31,
2025 | |
| — | | |
| — | | |
| 5,750,000 | | |
$ | 575 | | |
$ | 24,425 | | |
$ | (30,424 | ) | |
$ | (5,424 | ) |
Fair Value of Public
Warrants included in Public Units | |
| — | | |
| — | | |
| — | | |
| — | | |
| 3,526,667 | | |
| — | | |
| 3,526,667 | |
Capital contribution
from Sponsor | |
| — | | |
| — | | |
| — | | |
| — | | |
| 181,750 | | |
| — | | |
| 181,750 | |
Sale of Private
Placement Units | |
| 351,825 | | |
| 35 | | |
| — | | |
| — | | |
| 3,518,215 | | |
| — | | |
| 3,518,250 | |
Issuance of Representative Shares | |
| 229,425 | | |
| 23 | | |
| — | | |
| — | | |
| 2,294,227 | | |
| — | | |
| 2,294,250 | |
Allocated value
of transaction costs to warrants | |
| — | | |
| — | | |
| — | | |
| — | | |
| (192,678 | ) | |
| — | | |
| (192,678 | ) |
Remeasurement of
Class A ordinary shares to redemption value | |
| — | | |
| — | | |
| — | | |
| — | | |
| (9,352,606 | ) | |
| (4,268,345 | ) | |
| (13,620,951 | ) |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (61,710 | ) | |
| (61,710 | ) |
Balance
– June 30, 2025 | |
| 581,250 | | |
$ | 58 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | — | | |
$ | (4,360,479 | ) | |
$ | (4,359,846 | ) |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
YORKVILLE ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
FOR THE PERIOD FROM MARCH
3, 2025 (INCEPTION) THROUGH JUNE 30, 2025
Cash Flows from Operating Activities: | |
| |
Net loss | |
$ | (92,134 | ) |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | |
Formation, general and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | |
| 12,762 | |
Formation, general and administrative expenses paid by Sponsor under promissory note – related party | |
| 41,195 | |
Changes in operating assets and liabilities: | |
| | |
Prepaid expenses | |
| (85,000 | ) |
Accounts payable | |
| 30,680 | |
Accrued expenses | |
| 8,801 | |
Net cash used in operating activities | |
| (83,696 | ) |
| |
| | |
Cash Flows from Investing Activities: | |
| | |
Investment of cash in Trust Account | |
| (173,362,500 | ) |
Net cash used in investing activities | |
| (173,362,500 | ) |
| |
| | |
Cash Flows from Financing Activities: | |
| | |
Proceeds from sale of Units | |
| 172,500,000 | |
Proceeds from Private Placement Units | |
| 3,518,250 | |
Payment of underwriting fee | |
| (1,155,750 | ) |
Capital contribution from Sponsor | |
| 181,750 | |
Payment of offering costs | |
| (130,224 | ) |
Net cash provided by financing activities | |
| 174,914,026 | |
| |
| | |
Net Change in Cash and Cash Equivalents | |
| 1,467,830 | |
Cash and Cash Equivalents - Beginning | |
| — | |
Cash and Cash Equivalents - Ending | |
$ | 1,467,830 | |
| |
| | |
Non-Cash Investing and Financing Activities: | |
| | |
Deferred offering costs included in accrued offering costs | |
$ | 573,472 | |
Deferred offering costs contributed by Sponsor through promissory note – related party | |
$ | 83,528 | |
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | |
$ | 12,238 | |
Deferred underwriter fee payable | |
$ | 5,175,000 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
YORKVILLE ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 1 — Organization and Business Operations
Yorkville Acquisition Corp. (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on March 3, 2025. The Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (the “Business Combination”). The Company has not selected any specific Business Combination target, and the Company
has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target
with respect to an initial Business Combination with the Company.
As of June 30, 2025, the Company has not commenced
any operations. All activity for the period from March 3, 2025 (inception) through June 30, 2025 relates to the Company’s formation
and the initial public offering (the “Initial Public Offering”), as defined below. The Company will not generate any operating
revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has
selected December 31 as its fiscal year end.
On June 30, 2025, the Company consummated the
Initial Public Offering of 17,250,000 units (the “Units” and, with respect to the Class A ordinary shares included in the
Units being offered, the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option
in the amount of 2,250,000 Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Each Unit consists of one Class A ordinary
share and one-third of one redeemable warrant (each, a “Public Warrant”). Each whole warrant entitles the holder to purchase
one Class A ordinary share at a price of $11.50 per share.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated sale of an aggregate 351,825 units (the “Private Placement Units” and, with respect
to the Class A ordinary shares included in the Private Placement Units being offered, the “Private Placement Shares”) at a
price of $10.00 per Private Placement Unit, in a private placement to the Company’s sponsor, Yorkville Acquisition Sponsor LLC (the
“Sponsor”) in the Initial Public Offering, generating gross proceeds of $3,518,250. Each Private Placement Unit consists of
one Class A ordinary share (each, a “Private Placement Share”) and one-third of one redeemable warrant (each, a “Private
Placement Warrant”). Each whole Private Placement Warrant entitles the holder to purchase one Class A ordinary share at a price
of $11.50 per share.
Transaction costs amounted to $9,424,463, consisting
of $1,155,750 of cash underwriting fee, $5,175,000 of deferred underwriting fee, $2,294,250 for issuance of representative shares, and
$799,463 of other offering costs.
The Company’s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account
(as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account)
at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination
if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able
to successfully effect a Business Combination.
Following the closing of the Initial Public Offering, on June 30, 2025,
an amount of $173,362,500 ($10.05 per Unit) from the net proceeds of the sale of the Units and the Private Placement Units, was placed
in the trust account (the “Trust Account”), with Continental Stock Transfer & Trust Company acting as trustee. The funds
are to be initially invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market
funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government
treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the
intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment
Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based
on the management team’s ongoing assessment of all factors related to the Company’s potential status under the Investment
Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the trust account
in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust
Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the
Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the Company’s
initial Business Combination, (ii) the redemption of the Company’s Public Shares if the Company is unable to complete the initial
Business Combination within 24 months from the closing of the Initial Public Offering or by such earlier liquidation date as the
Company’s board of directors may approve (the “Completion Window”), subject to applicable law, or (iii) the redemption
of the Company’s Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and
restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow
redemption in connection with the initial Business Combination or to redeem 100% of the Company’s Public Shares if the Company has
not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions
relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could
become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s
public shareholders.
The Company will provide the Company’s public shareholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in
connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means
of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or
conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their
shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days
prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less
taxes payable (other than excise or similar taxes)), divided by the number of then outstanding Public Shares, subject to the limitations.
The amount in the Trust Account is initially anticipated to be $10.05 per Public Share. The ordinary shares subject to redemption were
recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing
Liabilities from Equity.”
The Company will have only the duration of the Completion Window to
complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion
Window, the Company will as promptly as reasonably possible but not more than ten business days thereafter, redeem the
Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned on the funds held in the Trust Account (less taxes payable (other than excise or similar taxes) and up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full and complete
payment for the Public Shares and completely extinguish public shareholders’ rights as shareholders (including the right to receive
further liquidation or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for
claims of creditors and subject to the other requirements of applicable law.
The Sponsor, officers and directors have entered into a letter agreement
with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (as
defined in Note 6) and Public Shares in connection with the completion of the initial Business Combination; (ii) waive their redemption
rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association; (iii) waive their rights to liquidating distributions from the Trust
Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Completion Window,
although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the
Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside
the Trust Account; and (iv) vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public
Offering (including in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements
of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination) in favor of the
initial Business Combination.
The Company’s Sponsor has agreed that it will be liable to the
Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target
business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination
agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual
amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per share
due to reductions in the value of the trust assets, less taxes payable (other than excise or similar taxes), provided that such liability
will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies
held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity
of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933,
as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations,
nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and the Company
believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would
be able to satisfy those obligations.
Liquidity and Capital Resources
As of June 30, 2025, the Company had $1,467,830
of cash and working capital of $815,154. Further, the Company has incurred and expects to continue to incur significant costs in pursuit
of its financing and acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance
with ASC 205-40, “Presentation of Financial Statements — Going Concern”, as of June 30, 2025, the Company
has sufficient liquidity for the working capital needs of the Company until a minimum of one year from the date of issuance of this financial
statement. The Company cannot assure that its plans to consummate an Initial Business Combination will be successful.
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities
and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared
in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.
Accordingly, the financial statements do not include all the information and footnotes necessary for a complete presentation of financial
position, results of operations, or cash flows.
In the opinion of management, the accompanying
unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair
presentation of the financial position, operating results and cash flows for the periods presented.
Emerging Growth Company Status
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the
“JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its
periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of condensed financial statements
in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the
reported amounts of expenses during the reporting period.
Making estimates requires management to exercise
significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,467,830 in cash and no cash
equivalents as of June 30, 2025.
Cash Held in Trust Account
As of June 30, 2025, the assets held in Trust
Account, amounting to $173,362,500, were held in cash.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of the ASC 340-10-S99 and
SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally of professional
and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,”
addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this
guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and Public Warrants, using
the residual method by allocating Initial Public Offering proceeds first to assigned value of the Public Warrants and then to the Class A
ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public
Warrants and Private Placement Units were charged to shareholders’ deficit as the Public and Private Placement Warrants, after management’s
evaluation, were accounted for under equity treatment.
Transaction costs amounted to $9,424,463, consisting of $1,155,750
of cash underwriting fee, $5,175,000 of deferred underwriting fee, $2,294,250 for issuance of representative shares, and $799,463 of other
offering costs.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximate
the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Fair value is defined as the price that would
be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement
date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
|
|
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
|
|
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Income Taxes
The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income
taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets
and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods
in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing
authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2025, there were
no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be a Cayman Islands
exempted company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,
“Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair
value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the
balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required
within 12 months of the condensed balance sheet date.
Net Income (Loss) Per Ordinary Share
The Company has two classes of shares, Class A
ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies
with the accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed
by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with
redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The Company has not considered the effect of the
5,750,000 Public Warrants in the calculation of diluted net income (loss) per share, since the exercise of such warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
The following table presents a reconciliation
of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares:
| |
Three Months Ended | |
| |
June 30, 2025 | |
| |
Class A Redeemable | | |
Class A Non-redeemable | | |
Class B Non-redeemable | |
Basic net loss per ordinary shares: | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| |
Allocation of net loss, basic | |
$ | (2,772 | ) | |
$ | (93 | ) | |
$ | (73,232 | ) |
Denominator: | |
| | | |
| | | |
| | |
Basic weighted average ordinary shares outstanding | |
| 189,560 | | |
| 6,387 | | |
| 5,008,242 | |
Basic net loss per ordinary share | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | (0.01 | ) |
| |
| | | |
| | | |
| | |
Diluted net loss per ordinary shares: | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | |
Allocation of net loss, diluted | |
$ | (2,426 | ) | |
$ | (82 | ) | |
$ | (73,589 | ) |
Denominator: | |
| | | |
| | | |
| | |
Diluted weighted average ordinary shares outstanding | |
| 189,560 | | |
| 6,387 | | |
| 5,750,000 | |
Diluted net loss per ordinary share | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | (0.01 | ) |
| |
For the Period from March 3, 2025 (inception) through | |
| |
June 30, 2025 | |
| |
Class A Redeemable | | |
Class A Non-redeemable | | |
Class B Non-redeemable | |
Basic net loss per ordinary shares: | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| |
Allocation of net loss, basic | |
$ | (2,569 | ) | |
$ | (87 | ) | |
$ | (89,478 | ) |
Denominator: | |
| | | |
| | | |
| | |
Basic weighted average ordinary shares outstanding | |
| 143,750 | | |
| 4,844 | | |
| 5,006,250 | |
Basic net loss per ordinary share | |
$ | (0.02 | ) | |
$ | (0.02 | ) | |
$ | (0.02 | ) |
| |
| | | |
| | | |
| | |
Diluted net loss per ordinary shares: | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | |
Allocation of net loss, diluted | |
$ | (2,245 | ) | |
$ | (76 | ) | |
$ | (89,813 | ) |
Denominator: | |
| | | |
| | | |
| | |
Diluted weighted average ordinary shares outstanding | |
| 143,750 | | |
| 4,844 | | |
| 5,750,000 | |
Diluted net loss per ordinary share | |
$ | (0.02 | ) | |
$ | (0.02 | ) | |
$ | (0.02 | ) |
Warrant Instruments
The Company accounted for the Public Warrants and Private Placement
Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in
FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instruments under
equity treatment at their assigned values. Such guidance provides that the Public Warrants described above will not be precluded from
equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair
value are not recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC 815.
Class A Ordinary Shares Subject to Possible Redemption
The Public Shares contain a redemption feature which allows for the
redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer
in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public
Shares subject to possible redemption outside of permanent deficit as the redemption provisions are not solely within the control of the
Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable
shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering,
the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares
will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of June 30,
2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’
deficit section of the Company’s condensed balance sheet. As of June 30, 2025, the Class A ordinary shares subject to possible redemption
reflected in the condensed balance sheet are reconciled in the following table:
Gross proceeds from Initial Public Offering | |
$ | 172,500,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (3,526,667 | ) |
Offering costs allocated to Class A ordinary shares subject to possible redemption | |
| (9,231,784 | ) |
Plus: | |
| | |
Accretion of Class A ordinary shares subject to possible redemption | |
| 13,620,951 | |
Class A ordinary shares subject to possible redemption at June 30, 2025 | |
$ | 173,362,500 | |
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07,
“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The
amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported
measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation
of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate
resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods,
and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing
segment disclosures in Topic 280. The ASU is effective for fiscal years beginning after December 15, 2023, and interim
periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on
March 3, 2025, the date of its inception.
Management does not believe that any other recently
issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
Note 3 — Initial Public Offering
Pursuant to the Initial Public Offering on June
30, 2025, the Company sold 17,250,000 Units at a purchase price of $10.00 per Unit, which includes the full exercise of the underwriters’
over-allotment option in the amount of 2,250,000 Units. Each Unit consists of one Class A ordinary share and one-third of one redeemable
warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject
to adjustment. Each Public Warrant will become exercisable at the later of 12 months from the closing of this offering and 30 days
after the completion of the initial Business Combination and will expire five years after the completion of the initial Business
Combination, or earlier upon redemption or liquidation.
Note 4 — Private Placement
Simultaneously with the closing of the Initial
Public Offering, the Sponsor purchased an aggregate of 351,825 Private Placement Units, at a price of $10.00 per unit, or $3,518,250 in
the aggregate. Each Private Placement Unit consists of one Private Placement Share and one-third of one Private Placement Warrant. Each
whole Private Placement Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.
The Private Placement Warrants will be identical to the Public Warrants
sold in the Initial Public Offering except that, so long as they are held by the Sponsor, or their permitted transferees, the Private
Placement Warrants (i) will not be redeemable, (ii) may not (including the Class A ordinary shares issuable upon exercise
of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days
after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis, and (iv) will
be entitled to registration rights.
The Sponsor, officers and directors entered into a letter agreement
with the Company, pursuant to which they agreed to (i) waive their redemption rights with respect to any shares held by them in connection
with the completion of the initial Business Combination; (ii) waive their redemption rights with respect to any shares held by them
in connection with a shareholder vote to approve an amendment to the amended and restated memorandum and articles of association (A) to
modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination
or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Completion Window
or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity;
(iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement
Shares if the Company fails to complete an initial Business Combination within the Completion Window, although they will be entitled to
liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete an initial
Business Combination within the prescribed time frame and to liquidating distributions from assets outside the Trust Account; and (iv) vote
any Founder Shares and Private Placement Shares held by them and any Public Shares purchased during or after this offering (including
in open market and privately-negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule 14e-5
under the Exchange Act, which would not be voted in favor of approving the Business Combination transaction) in favor of the initial
Business Combination.
Note 5 — Segment Information
ASC Topic 280, “Segment Reporting”,
establishes standards for companies to report, in their financial statements, information about operating segments, products, services,
geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities
from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated
by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.
The Company’s chief operating decision maker
(“CODM”) has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has
determined that the Company only has one reporting segment.
The CODM assesses performance for the single segment
and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or
loss. The measure of segment assets is reported on the condensed balance sheet as total assets. When evaluating the Company’s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total
assets, which include the following:
| |
June 30, 2025 | |
Cash | |
$ | 1,467,830 | |
Cash held in Trust Account | |
$ | 173,362,500 | |
| |
| | |
For the Period from | |
| |
For the Three Months Ended June 30, 2025 | | |
March 3, 2025 (inception) Through June 30, 2025 | |
Formation, general and administrative expenses | |
$ | 63,574 | | |
$ | 93,998 | |
The CODM reviews cash held in Trust Account to
measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining
compliance with the Trust Agreement.
Formation, general and administrative expenses
are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination
or similar transaction within the Completion Window. The CODM also reviews formation, general and administrative expenses to manage, maintain
and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation, general and administrative
expenses, as reported on the condensed statements of operations, are the significant segment expenses provided to the CODM on a regular
basis.
All other segment items included in net loss are reported on the condensed
statements of operations and described within their respective disclosures.
Note 6 — Related Party Transactions
Founder Shares
On March 5, 2025, the Company issued an aggregate
of 5,750,000 Class B ordinary shares, $0.0001 par value (the “Founder Shares”), in exchange for a $25,000 payment (approximately
$0.004 per share) from the Sponsor to cover certain expenses on behalf of the Company.
As used herein, unless the context otherwise requires, “Founder
Shares” shall be deemed to include the Public Shares issuable upon conversion thereof. The Founder Shares are identical to the Public
Shares included in the Units being sold in the Initial Public Offering except that the Founder Shares automatically convert into
Public Shares at the time of the initial Business Combination (with such conversion taking place immediately prior to, simultaneously
with, or immediately following the time of the initial Business Combination, as may be determined by the directors of the Company) or
earlier at the option of the holder and are subject to certain transfer restrictions, as described in more detail below. The Sponsor has
agreed to forfeit up to an aggregate of 750,000 Founder Shares to the extent that the over-allotment option is not exercised in full by
the underwriters so that the Founder Shares will represent approximately 25% of the Company’s issued and outstanding shares
after the Initial Public Offering. If the Company increases or decreases the size of the offering, the Company will effect a share capitalization
or share surrender, as applicable, immediately prior to the consummation of the Initial Public Offering in such amount as to maintain
the Founder Share ownership of the Company’s shareholders prior to the Initial Public Offering at 25% of the Company’s issued
and outstanding ordinary shares upon the consummation of the Initial Public Offering. The Sponsor will not be entitled to redemption rights
with respect to any Founder Shares and any Public Shares held by the Sponsor in connection with the completion of the initial Business
Combination. If the initial Business Combination is not completed within 24 months from the closing of the Initial Public Offering,
the Sponsor will not be entitled to rights to liquidating distributions from the Trust Account with respect to any Founder Shares held
by it.
The Sponsor has agreed not to transfer, assign
or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination
or (B) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A ordinary shares
equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, rights issuances, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial
Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other
similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities
or other property.
Promissory Note — Related Party
The Sponsor agreed to loan the Company an aggregate of up to $300,000
to be used for a portion of the expenses of the Initial Public Offering (the “Promissory Note”). The Promissory Note was non-interest
bearing, unsecured and due at the earlier of March 25, 2026, or the closing of the Initial Public Offering. As of June 30, 2025, the Company
had borrowed $124,723 under the Promissory Note. The Promissory Note was non-interest bearing and $124,723 is outstanding as of June 30,
2025.
Related Party Loans
In addition, in order to finance transaction costs
in connection with its initial Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes
its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, such loans
may be convertible into private placement-equivalent units of the post-Business Combination entity at a price of $10.00 per unit (“Working
Capital Units”), with each unit comprised of one Class A ordinary share (“Working Capital Share”) and one-third
of one warrant to purchase one Class A ordinary share at an exercise price of $11.50 per share (“Working Capital Warrant”).
As of June 30, 2025, the Company had no borrowings under the Working Capital Loans.
Additionally, in order to finance potential extensions, the Sponsor
or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company up to $3,450,000
in extension loans (assuming the underwriters exercise their over-allotment option and no Public Shares have been redeemed at the time
of each extension), as may be required (“Extension Loans”). The Extension Loans may be convertible private placement-equivalent
units of the post-business combination entity at a price of $10.00 per unit (“Extension Units”), with each unit comprised
of one Class A ordinary share (“Extension Share”) and one-third of one warrant to purchase one Class A ordinary
share at an exercise price of $11.50 per share (“Extension Warrant”). As of June 30, 2025, the Company had no borrowings under
the Extension Loans.
Note 7 — Commitments and Contingencies
Risks and Uncertainties
United States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the ongoing wars between Russia and Ukraine and between
Israel and Hamas, Iran and its proxies in certain of the neighboring countries in the Middle East. In response to the ongoing war between
Russia and Ukraine, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe,
and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive
actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the
Society for Worldwide Interbank Financial Telecommunication (“SWIFT”) payment system. Certain countries, including the United States,
have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions
among a number of nations. The ongoing wars between Russia and Ukraine and between Israel and Hamas, Iran and its proxies in certain of
the neighboring countries in the Middle East and the resulting measures that have been taken, and could be taken in the future, by NATO,
the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created
global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing
conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit
and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any
resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital
markets.
Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the ongoing wars between Russian
and Ukraine, Israel and Hamas, Iran and its proxies in certain of the neighboring countries in the Middle East and subsequent sanctions
or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with
which the Company may ultimately consummate an initial Business Combination.
Registration Rights
The holders of the Founder Shares, placement units, Working Capital
Units and Extension Units that may be issued upon conversion of loans made by the Sponsor or one of its affiliates, and their
permitted transferees, will have registration rights to require the Company to register a sale of any of its securities held by them (in
the case of the Founder Shares, only after conversion to our Class A ordinary shares) pursuant to a registration rights agreement
to be signed prior to or on the effective date of this offering. These holders will be entitled to make up to three demands, excluding
short form registration demands, that we register such securities for sale under the Securities Act. In addition, these holders will have
“piggy-back” registration rights to include such securities in other registration statements filed by us and rights to require
us to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement
provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until
termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option from the date of the Initial Public Offering to purchase up to an additional 2,250,000 units to cover over-allotments, if any.
On June 30, 2025, the underwriters fully exercised their over-allotment option.
The underwriters were paid a cash underwriting discount of $1,155,750
($0.067 per Unit offered in the Initial Public Offering). Additionally, the underwriters are entitled to a deferred fee of $0.30 per Unit,
or $5,175,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event
that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Representative Shares
The Company issued to Clear Street and/or
its designees 229,425 Class A ordinary shares (the “Representative Shares”) upon the consummation of the Initial
Public Offering. The Company estimated the fair value of the Representative Shares to be $2,294,250. The fair value of the
Representative Shares was determined to be $10.00 per share as the Representative Shares were issued at approximately the same time
as the units sold at $10.00 per unit in the Initial Public Offering. The Company accounted for the Representative Shares as an
expense of the Initial Public Offering, resulting in a charge directly to shareholder’s equity and will not require remeasurement after issuance. Clear Street (and any of its
designees to whom the Representative Shares are issued) agree not to transfer, assign or sell any such shares without the
Company’s prior consent until the completion of a Business Combination. In addition, the Representative Shares are deemed to
be underwriting compensation by the Financial Industry Regulatory Authority, Inc. (“FINRA”) pursuant to FINRA
Rule 5110 and will, accordingly, be subject to certain transfer restrictions or a period of 180 days beginning on the date
of commencement of sales of the Units in the Initial Public Offering. Furthermore, Clear Street agreed (and any of its
designees to whom the Representative Shares are issued agree) (i) to waive its redemption rights (or right to participate in
any tender offer) with respect to such shares in connection with the completion of the Company’s initial Business Combination
and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company
fails to complete a Business Combination within the Completion Window.
Note 8 — Shareholders’ Deficit
Preference Shares — The Company
is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. At June 30, 2025, there were no preference
shares issued or outstanding.
Class A Ordinary Shares —
The Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $0.0001 each. At June 30, 2025, 581,250
shares of Class A ordinary shares were issued and outstanding, excluding 17,250,000 shares subject to possible redemption.
Class B Ordinary Shares —
The Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $0.0001 each. At June 30, 2025, there
were 5,750,000 Class B ordinary shares issued and outstanding.
The Founder Shares will automatically convert into Class A ordinary
shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the
holder on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or any other
equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with
the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares
will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with
respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B
ordinary shares will equal, in the aggregate, 25% of the sum of (i) the total number of all Class A ordinary shares outstanding
upon the completion of the Initial Public Offering (including any Class A ordinary shares issued pursuant to the underwriters’
over-allotment option and excluding the Class A ordinary shares underlying the Private Placement Warrants issued to the Sponsor),
plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of
the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial
Business Combination and any private placement-equivalent warrants issued to the Sponsor or any of its affiliates or to the Company’s
officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by Public
Shareholders in connection with an initial Business Combination; provided that such conversion of Founder Shares will never occur on a
less than one-for-one basis.
Except as set forth herein, holders of record
of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all
matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as required
by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum
and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being
entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company is generally
required to approve any matter voted on by the Company’s shareholders. Approval of certain actions requires a special resolution
under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by
such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting,
and pursuant to the Company’s amended and restated memorandum and articles of association, such actions include amending the amended
and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is no
cumulative voting with respect to the appointment of directors, meaning, following the Company’s initial Business Combination, the
holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation
of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the right to vote on the appointment
and removal of directors and (ii) be entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including
any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result
of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class A ordinary shares
will not be entitled to vote on these matters during such time. These provisions of the amended and restated memorandum and articles of
association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment
is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as,
being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company.
Warrants — As of June 30, 2025, there
were 5,867,275 warrants outstanding, including 5,750,000 Public Warrants and 117,275 Private Placement Warrants. Each whole warrant entitles
the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The
warrants cannot be exercised until the later of 12 months from the closing of this offering and 30 days after the completion
of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion
of the initial Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any
Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise
unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the Public Warrants
is then effective and a prospectus relating thereto is current. No Public Warrant will be exercisable and the Company will not be obligated
to issue a Class A ordinary share upon exercise of a Public Warrant unless the Class A ordinary share issuable upon such Public
Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered
holder of the Public Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect
to a Public Warrant, the holder of such Public Warrant will not be entitled to exercise such Public Warrant and such Public Warrant may
have no value and expire worthless. In no event will the Company be required to net cash settle any Public Warrant. In the event that
a registration statement is not effective for the exercised Public Warrants, the purchaser of a Unit containing such Public Warrant will
have paid the full purchase price for the Unit solely for the Class A ordinary share underlying such Unit.
Under the terms of the warrant agreement, the
Company will agree that, as soon as practicable, but in no event later than 20 business days after the closing of its Business Combination,
it will use commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial
Public Offering or a new registration statement covering the registration under the Securities Act of the Class A ordinary
shares issuable upon exercise of the Public Warrants and thereafter will use its commercially reasonable efforts to cause the same to
become effective within 60 business days following the Company’s initial Business Combination and to maintain a current prospectus
relating to the Class A ordinary shares issuable upon exercise of the Public Warrants until the expiration of the Public Warrants
in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable
upon exercise of the Public Warrants is not effective by the sixtieth (60th) business day after the closing of the initial
Business Combination, Public Warrant holders may, until such time as there is an effective registration statement and during any period
when the Company will have failed to maintain an effective registration statement, exercise Public Warrants on a “cashless basis”
in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A
ordinary shares are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy
the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option,
require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration
statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available.
If the holders exercise their Public Warrants
on a cashless basis, they would pay the warrant exercise price by surrendering the Public Warrants for that number of Class A ordinary
shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the Public
Warrants, multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price
of the Public Warrants by (y) the fair market value. The “fair market value” is the average reported closing price of
the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice
of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of Public Warrants, as applicable.
Redemption of Warrants When the Price per Class
A Ordinary Share Equals or Exceeds $18.00: The Company may redeem the outstanding Public Warrants:
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.01 per Public Warrant; |
|
● |
upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and |
|
|
|
|
● |
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Public Warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of the Company’s initial Business Combination and ending three business days before the Company sends the notice of redemption to the Public Warrant holders. |
Additionally, if the number of outstanding Class A
ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a subdivision of ordinary shares
or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A
ordinary shares issuable on exercise of each Public Warrant will be increased in proportion to such increase in the outstanding ordinary
shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary
shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal
to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other
equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the
quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market value. For these
purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining
the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well
as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of
Class A ordinary shares as reported during the ten (10) trading day period ending on the trading day prior to the first
date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the
right to receive such rights.
Note 9 — Fair Value Measurements
The fair value of the Company’s financial
assets and liabilities reflects Management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
| Level 1: | Quoted prices in active markets for identical assets or liabilities.
An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency
and volume to provide pricing information on an ongoing basis. |
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level
2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities
in markets that are not active. |
| Level 3: | Unobservable inputs based on assessment of the assumptions that
market participants would use in pricing the asset or liability. |
The following table presents information about
the Company’s assets that are measured at fair value on June 30, 2025, and indicates the fair value hierarchy of the valuation inputs
the Company utilized to determine such fair value:
| |
June 30, 2025 | |
| |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Assets: | |
| | |
| | |
| |
Cash held in Trust Account | |
$ | 173,362,500 | | |
$ | — | | |
$ | — | |
Upon consummating the Initial Public Offering
on June 30, 2025, the Public Warrants were valued using a Black-Scholes Simulation Model, resulting in a fair value of $3,526,667. The
Public Warrants were valued using Level 3 inputs and have been classified within shareholders’ deficit and will not require remeasurement
after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public
Warrants:
| |
June 30,
2025 | |
Implied Class A Ordinary Share price | |
$ | 11.02 | |
Exercise price | |
$ | 11.50 | |
Simulation term (years) | |
| 7.00 | |
Risk-free rate | |
| 3.98 | % |
Selected volatility | |
| 2.77 | % |
Calculated value per warrant | |
$ | 0.68 | |
Market adjustment | |
| 29.26 | % |
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions
that occurred after the condensed balance sheet date through the date that the condensed financial statements were available to be issued.
Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed
financial statements.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
We refer to this report as our “Quarterly
Report on Form 10-Q” and references to “we,” “us” or the “Company” herein reference Yorkville
Acquisition Corp., a Cayman Islands exempted company. Reference to our “management” or our “management team” refer
to our officers and directors, and references to the “Sponsor” refer to Yorkville
Acquisition Sponsor LLC, a Delaware limited liability company. The following discussion and analysis of the Company’s financial
condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere
in this Quarterly Report on Form 10-Q. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially
from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including,
without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could
cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section
of the Company’s final prospectus for its Initial Public Offering (as defined below) filed with the U.S. Securities and Exchange
Commission (the “SEC”) on June 30, 2025. The Company’s securities filings can be accessed on the EDGAR section of the
SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or
obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on March
3, 2025 as a Cayman Island exempted company and formed for the purpose of effecting
a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses,
which we refer to throughout this Quarterly Report as our “initial business combination”. We intend to effectuate our initial
business combination using cash from the proceeds of the initial public offering (the “Initial Public Offering”) and the sale
of the Private Placement Warrants, the proceeds of the sale of our shares in connection with our initial business combination (pursuant
to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise),
shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
On June 30, 2025, we consummated our Initial Public
Offering of 17,250,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Simultaneously with the closing of the Initial Public Offering,
we consummated the sale of 351,825 Private Placement Units, in a private placement to the Sponsor, at a price of $10.00 per Private Placement
Unit, generating gross proceeds of $3,518,250.
We incurred offering costs of $9,424,463, consisting
of $1,155,750 of cash underwriting fee, $5,175,000 of deferred underwriting fee, $2,294,250 for issuance of representative shares, and
$799,463 of other offering costs.
Upon the closing of the Initial Public Offering and the private placement,
$173,362,500 ($10.05 per Unit) of the net proceeds of the sale of the Units and the Private Placement Units were placed in a U.S.-based
trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company
acting as trustee, and will be invested only in United States “government securities” within the meaning of Section 2(a)(16)
of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7
promulgated under the Investment Company Act which invests only in direct U.S. government treasury obligations, as determined by us, until
the earlier of: (i) the completion of an initial business combination and (ii) the distribution of the Trust Account as described
below.
Results of Operations
As of June 30, 2025, we had not commenced any operations. All activity
from inception through June 30, 2025 relates to our formation and our Initial Public Offering, and, since the completion of the Initial
Public Offering, our search for a target to consummate an initial business combination. We will not generate any operating revenues until
after the completion of an initial business combination, at the earliest. We will generate non-operating income in the form of interest
and dividend income from the proceeds derived from the Initial Public Offering and placed in the Trust Account. We expect to incur increased
expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due
diligence expenses.
For the three months ended June 30, 2025, we had
net loss of $61,710, which consisted of formation, general and administrative expenses of $63,574, offset by interest income of $1,864.
For the period from March 3, 2025 (inception)
through June 30, 2025, we had net loss of $92,134, which consisted of formation, general and administrative expenses of $93,998, offset
by interest income of $1,864.
Liquidity, Capital Resources and Going Concern
As of June 30, 2025, we had $1,467,830 in cash
and cash equivalents held outside of the Trust Account and a working capital deficit of $815,154 (excluding cash and marketable securities
held in the Trust Account and the deferred underwriter fee payable).
Until the consummation of the Initial Public Offering, our only source
of liquidity was from the $25,000 of proceeds from our Sponsor’s purchase of Class B ordinary shares, par value $0.0001 per share,
and a loan of $124,723 from our Sponsor pursuant to a promissory note to cover certain expenses.
Following our Initial Public Offering and the sale of Private Placement
Units to the Sponsor, a total of $173,362,500 was placed in the Trust Account.
For the period from March 3, 2025 (inception)
through June 30, 2025, net cash used in operating activities was $83,696. Net loss of $92,134, was adjusted by formation, general and
administrative expenses paid by Sponsor under promissory note – related party of $41,195, formation, general and administrative
expenses paid by Sponsor in exchange for issuance of Class B ordinary shares of $12,762, and $8,438 changes in operating assets and liabilities.
Net cash used in investing activities was $173,362,500 related to the funding of the Trust Account. Net cash provided by financing activities
was $174,914,026 related to $171,344,250 of net proceeds from the issuance of ordinary shares, $3,518,250 of proceeds from sale of Private
Placement Units, and $181,750 of capital contributions from the Sponsor, offset by $130,224 payments of deferred offering costs.
As of June 30, 2025, we had marketable securities held in the Trust
Account of $173,362,500 consisting of securities held in a money market fund that invests in U.S. Treasury securities with a maturity
of 185 days or less. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest
earned on the Trust Account (less deferred underwriting fees and income taxes payable), to complete our initial business combination.
To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our initial business combination,
the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses,
make other acquisitions and pursue our growth strategies.
As of June 30, 2025, we had cash and cash equivalents of $1,467,830
held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses,
perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective
target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses,
and structure, negotiate and complete an initial business combination.
We may need to raise additional funds in order
to meet the expenditures required for operating our business prior to our initial business combination. We expect to incur significant
costs related to identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination. These
conditions raise substantial doubt about our ability to continue as a going concern for a period of time within one year from the date
that the financial statements accompanying this Quarterly Report on Form 10-Q are issued.
In order to fund working capital deficiencies or finance transaction
costs in connection with an initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors
may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned
amounts out of the proceeds of the Trust Account released to us. In the event that an initial business combination does not close, we
may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account
would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units of the post-business combination entity
at a price of $10.00 per unit, at the option of the lender. As of June 30, 2025, we did not have any outstanding working capital loans.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities as of June 30, 2025.
The underwriters of the Initial Public Offering are entitled to a deferred
underwriting discount of $0.30 per Unit, or $5,175,000. The deferred fee will become payable to the underwriters from the amounts held
in the Trust Account solely in the event that we complete an initial business combination, subject to the terms of the underwriting agreement.
Critical Accounting Estimates
The preparation of financial statements and related
disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
We have not identified any critical accounting estimates as of June 30, 2025.
Recent Accounting Pronouncements
In November 2023, the FASB issued Accounting
Standard Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”),
which is intended to improve reportable segment disclosure requirements, primarily through additional disclosures about significant
segment expenses. The standard was effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal
years beginning after December 15, 2024, with early adoption permitted. We adopted this ASU on March 3, 2025, the date of our
inception. Adoption of the new standard did not have a material impact on our financial statements.
In December 2023, the FASB issued Accounting Standards
Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures
primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the
income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state
and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling
items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose
net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five
percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning
after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have
on its financial position, results of operations or cash flows.
The Company’s management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on
the accompanying financial statements.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures Evaluation
of Disclosure Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.
Under the supervision and with the participation
of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation
of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2025, as such term is
defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal
financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures
were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed
by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
SEC’s rules and forms.
Changes in Internal Control over Financial
Reporting
There were no changes in our internal control
over financial reporting that occurred during the quarter ended June 30, 2025, covered by this Quarterly Report on Form 10-Q that has
materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.
None
Item 1A. Risk Factors.
In addition to the other information set forth
in this report, you should carefully consider the factors discussed in the Risk Factors section of the final prospectus in connection
with the Initial Public Offering filed with the SEC on June 30, 2025, which could materially affect our business, financial condition
or future results. There have been no material changes during the 2025 fiscal year to the risk factors that were included in the final
prospectus.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
None
Item 3. Defaults Upon Senior Securities.
None
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None
Item 6. Exhibits.
Exhibit No.
|
|
Description |
31.1 |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2 |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32 |
|
Certification Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101.INS |
|
Inline XBRL Instance Document. |
101.SCH |
|
Inline XBRL Taxonomy Extension
Schema Document. |
101.CAL |
|
Inline XBRL Taxonomy Extension
Calculation Linkbase Document. |
101.DEF |
|
Inline XBRL Taxonomy Extension
Definition Linkbase Document. |
101.LAB |
|
Inline XBRL Taxonomy Extension
Label Linkbase Document. |
101.PRE |
|
Inline XBRL Taxonomy Extension
Presentation Linkbase Document. |
104 |
|
Cover Page Interactive
Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
YORKVILLE ACQUISITION CORP. |
|
|
|
|
By: |
/s/ Michael Rosselli |
|
|
Name: |
Michael Rosselli |
|
|
Title: |
Chief Financial Officer |
|
|
|
(Principal Financial and Accounting Officer) |
|
|
|
Dated: August 14, 2025 |
|
|
00-0000000
P5Y
http://fasb.org/srt/2025#ChiefFinancialOfficerMember
P5Y
0002064658
false
Q2
--12-31
0002064658
2025-01-01
2025-06-30
0002064658
yorku:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember
2025-01-01
2025-06-30
0002064658
yorku:ClassAOrdinarySharesParValue00001PerShareMember
2025-01-01
2025-06-30
0002064658
yorku:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember
2025-01-01
2025-06-30
0002064658
us-gaap:CommonClassAMember
2025-08-14
0002064658
us-gaap:CommonClassBMember
2025-08-14
0002064658
2025-06-30
0002064658
us-gaap:RelatedPartyMember
2025-06-30
0002064658
us-gaap:CommonClassAMember
2025-06-30
0002064658
us-gaap:CommonClassBMember
2025-06-30
0002064658
2025-04-01
2025-06-30
0002064658
2025-03-03
2025-06-30
0002064658
yorku:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2025-04-01
2025-06-30
0002064658
yorku:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2025-03-03
2025-06-30
0002064658
yorku:NonRedeemableClassAOrdinarySharesMember
2025-04-01
2025-06-30
0002064658
yorku:NonRedeemableClassAOrdinarySharesMember
2025-03-03
2025-06-30
0002064658
yorku:NonRedeemableClassBOrdinarySharesMember
2025-04-01
2025-06-30
0002064658
yorku:NonRedeemableClassBOrdinarySharesMember
2025-03-03
2025-06-30
0002064658
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-03-02
0002064658
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-03-02
0002064658
us-gaap:AdditionalPaidInCapitalMember
2025-03-02
0002064658
us-gaap:RetainedEarningsMember
2025-03-02
0002064658
2025-03-02
0002064658
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-03-03
2025-03-31
0002064658
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-03-03
2025-03-31
0002064658
us-gaap:AdditionalPaidInCapitalMember
2025-03-03
2025-03-31
0002064658
us-gaap:RetainedEarningsMember
2025-03-03
2025-03-31
0002064658
2025-03-03
2025-03-31
0002064658
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-03-31
0002064658
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-03-31
0002064658
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0002064658
us-gaap:RetainedEarningsMember
2025-03-31
0002064658
2025-03-31
0002064658
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0002064658
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0002064658
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-06-30
0002064658
us-gaap:RetainedEarningsMember
2025-04-01
2025-06-30
0002064658
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-06-30
0002064658
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-06-30
0002064658
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0002064658
us-gaap:RetainedEarningsMember
2025-06-30
0002064658
us-gaap:IPOMember
2025-03-03
2025-06-30
0002064658
us-gaap:OverAllotmentOptionMember
2025-03-03
2025-06-30
0002064658
us-gaap:OverAllotmentOptionMember
2025-06-30
0002064658
us-gaap:CommonClassAMember
2025-03-03
2025-06-30
0002064658
us-gaap:PrivatePlacementMember
2025-03-03
2025-06-30
0002064658
us-gaap:PrivatePlacementMember
2025-06-30
0002064658
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2025-03-03
2025-06-30
0002064658
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2025-06-30
0002064658
yorku:PublicWarrantsMember
2025-03-03
2025-06-30
0002064658
yorku:ClassARedeemableMember
2025-04-01
2025-06-30
0002064658
yorku:ClassANonredeemableMember
2025-04-01
2025-06-30
0002064658
yorku:ClassBNonredeemableMember
2025-04-01
2025-06-30
0002064658
yorku:ClassARedeemableMember
2025-03-03
2025-06-30
0002064658
yorku:ClassANonredeemableMember
2025-03-03
2025-06-30
0002064658
yorku:ClassBNonredeemableMember
2025-03-03
2025-06-30
0002064658
yorku:ClassAOrdinaryShareSubjectToPossibleRedemptionMember
2025-03-03
2025-06-30
0002064658
yorku:ClassAOrdinaryShareSubjectToPossibleRedemptionMember
2025-06-30
0002064658
us-gaap:IPOMember
2025-06-30
0002064658
yorku:PublicWarrantMember
2025-03-03
2025-06-30
0002064658
yorku:SponsorMember
us-gaap:IPOMember
2025-06-30
0002064658
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2025-06-30
0002064658
us-gaap:AllOtherSegmentsMember
2025-06-30
0002064658
us-gaap:AllOtherSegmentsMember
2025-04-01
2025-06-30
0002064658
us-gaap:AllOtherSegmentsMember
2025-03-03
2025-06-30
0002064658
yorku:FounderMember
us-gaap:CommonClassBMember
2025-03-05
2025-03-05
0002064658
yorku:FounderMember
us-gaap:CommonClassBMember
2025-03-05
0002064658
yorku:SponsorMember
us-gaap:CommonClassBMember
2025-03-05
2025-03-05
0002064658
yorku:SponsorMember
us-gaap:CommonClassBMember
2025-03-05
0002064658
yorku:FounderMember
2025-03-05
2025-03-05
0002064658
2025-03-05
2025-03-05
0002064658
yorku:PromissoryNoteMember
us-gaap:RelatedPartyMember
2025-06-30
0002064658
yorku:WorkingCapitalLoansMember
us-gaap:RelatedPartyMember
2025-06-30
0002064658
yorku:WorkingCapitalWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonClassAMember
2025-06-30
0002064658
yorku:ExtensionLoansMember
us-gaap:RelatedPartyMember
2025-06-30
0002064658
yorku:ExtensionWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonClassAMember
2025-06-30
0002064658
us-gaap:CommonClassAMember
us-gaap:IPOMember
2025-03-03
2025-06-30
0002064658
us-gaap:CommonClassAMember
yorku:RepresentativeSharesMember
2025-01-01
2025-06-30
0002064658
yorku:RepresentativeSharesMember
2025-01-01
2025-06-30
0002064658
us-gaap:IPOMember
2025-01-01
2025-06-30
0002064658
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:CommonClassAMember
2025-06-30
0002064658
us-gaap:WarrantMember
2025-03-03
0002064658
us-gaap:WarrantMember
yorku:PublicWarrantMember
2025-03-03
0002064658
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2025-03-03
0002064658
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2025-03-03
0002064658
us-gaap:WarrantMember
2025-03-03
2025-06-30
0002064658
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:WarrantMember
2025-03-03
2025-06-30
0002064658
us-gaap:WarrantMember
2025-06-30
0002064658
yorku:BlackScholesSimulationModelMember
2025-01-01
2025-06-30
0002064658
us-gaap:FairValueInputsLevel1Member
2025-06-30
0002064658
us-gaap:FairValueInputsLevel2Member
2025-06-30
0002064658
us-gaap:FairValueInputsLevel3Member
2025-06-30
0002064658
us-gaap:MeasurementInputSharePriceMember
2025-06-30
0002064658
us-gaap:MeasurementInputExercisePriceMember
2025-06-30
0002064658
us-gaap:MeasurementInputExpectedTermMember
2025-06-30
0002064658
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-06-30
0002064658
us-gaap:MeasurementInputPriceVolatilityMember
2025-06-30
0002064658
yorku:MeasurementInputWarrantMember
2025-06-30
0002064658
us-gaap:MeasurementInputCommodityMarketPriceMember
2025-06-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure